Harvard Bioscience Inc.
HBIO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.88M
Close$
$-3.11
132.8% downside
Current Fair Value
132.8% downsideOvervalued by 132.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $42.88 Million |
|---|---|
| Enterprise Value | $84.19 Million |
| Earnings per Share | $-12.8 |
| Beta | 1.48 |
| Outstanding Shares | 4,526,000 |
Return
| Return on Equity | -159.13% |
|---|---|
| Return on Assets | -15.47% |
| Return on Invested Capital | 94.89% |
Valuation & Multiples
| P/E Ratio | -3.59 |
|---|---|
| PEG | -3.18 |
| Price to Sales | 0.5 |
| Price to Book Ratio | 9.48 |
| Enterprise Value to Revenue | 0.94 |
| Enterprise Value to EBIT | 1.72 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.57 |
| Debt to Equity | 6.44 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 10, 2026
EPS
-$0.06
Est. -$0.33Revenue
$22.20 M
Est. $21.80 MNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-$0.00
Consensus analyst estimateRevenue Estimate
$24.43 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.50%▼ 28.41% |
|---|---|
| Total Invested | $536,561▼ 93.55% |
| Investors Holding | 3▼ 31.00% |